These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3014284)

  • 1. Absence of antibodies to HTLV-III on Bougainville (Papua New Guinea).
    Hrdy DB; Carlson JR; Friedlaender JS
    Med J Aust; 1986 Jun; 144(13):723. PubMed ID: 3014284
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of human T cell leukemia virus type I infection in East Sepik Province, Papua New Guinea.
    Kazura JW; Saxinger WC; Wenger J; Forsyth K; Lederman MM; Gillespie JA; Carpenter CC; Alpers MA
    J Infect Dis; 1987 Jun; 155(6):1100-7. PubMed ID: 2883238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible nonspecific associations between malaria and HTLV-III/LAV.
    Biggar RJ
    N Engl J Med; 1986 Aug; 315(7):457-8. PubMed ID: 3016540
    [No Abstract]   [Full Text] [Related]  

  • 4. More on HTLV-III antibody testing in New York City.
    N Engl J Med; 1986 May; 314(18):1190-1. PubMed ID: 3007988
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a new assay for antibodies to LAV/HTLV III.
    Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
    J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disinfection and inactivation of HTLV-III/LAV.
    Ronalds CJ; Grint PC; Kangro HD
    J Infect Dis; 1986 May; 153(5):996-7. PubMed ID: 3009641
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of immunosuppression in healthy subjects from eastern Zaire who are positive for HTLV-III antibody.
    Kestens L; Biggar RJ; Melbye M; Bodner AJ; De Feyter M; Gigase PL
    N Engl J Med; 1985 Jun; 312(23):1517-8. PubMed ID: 2985998
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III: should testing ever be routine?
    Kinghorn GR
    Br Med J (Clin Res Ed); 1986 May; 292(6529):1202. PubMed ID: 3011182
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of evidence of HTLV-III endemicity in southern Africa.
    Lyons SF; Schoub BD; McGillivray GM; Sher R; Dos Santos L
    N Engl J Med; 1985 May; 312(19):1257-8. PubMed ID: 2985989
    [No Abstract]   [Full Text] [Related]  

  • 11. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 12. Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
    De Rossi A; Gallo P; Tavolato B; Callegaro L; Chieco-Bianchi L
    Acta Neurol Scand; 1986 Aug; 74(2):161-4. PubMed ID: 3022528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of antibodies to HTLV-III/LAV virus in family members who administer coagulation products in home treatment programmes.
    Ekert H; McNaught KL
    Med J Aust; 1986 Jun; 144(13):722-3. PubMed ID: 3014283
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of antibodies to HTLV-I and HIV in serum and cerebrospinal fluid of Italian patients with multiple sclerosis.
    Merelli E; Sola P; Montagnani G; Baldini E
    J Neurol Sci; 1988 Apr; 84(2-3):337-9. PubMed ID: 2837543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of antibody to HTLV-I and HIV in patients with multiple sclerosis from France and French West Indies.
    Gessain A; Abel L; De-The G; Vernant JC; Raverdy P; Guillard A
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):424-5. PubMed ID: 2874864
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of correlation between promiscuity and seropositivity to HTLV-III from a low-incidence area for AIDS.
    Calabrese LH; Proffitt MR; Rehm S; Lederman M; Carey JT; Houser HB; Edmonds K; Ellner JJ
    N Engl J Med; 1985 May; 312(19):1256-7. PubMed ID: 2985988
    [No Abstract]   [Full Text] [Related]  

  • 17. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report].
    Arosemena JR; Cuevas M; Ulloa E; Guerrero DM; Gómez B; Cantón-Dutary A; Reyes R; Quiroz E; de Britton RM; Brenes MM
    Rev Med Panama; 1986 May; 11(2):124-33. PubMed ID: 3018847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.